SP1 and breast cancer: Recent studies showed HIF-1 signaling was involved in lymphatic invasion through induction of platelet-derived growth factor B (PDGF-B) in breast cancer [50], vascular endothelial growth factor C (VEGF-C) [51] and SP1 in ESCC [52].